Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856

NCT05077501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Cognition Disorder

Interventions

DRUG: ACD856
DRUG: Placebo

Sponsor

AlzeCure Pharma